Medicine recalls
|
| |
| Canada: Recall: SANDOZ FESOTERODINE FUMARATE: The Diester impurity is out of specification in the affected lot(s) |
| |
Health Canada announces that Sandoz Canada Incorporated is recalling one lot of SANDOZ FESOTERODINE FUMARATE 8mg tablet (extended-release) (lot number: 2305011682) from retailers because the Diester impurity is out of specification in the affected lot.
The product is indicated for the treatment of patients with overactive bladder with symptoms of urinary frequency, urgency, or urge incontinence, or any combination of these symptoms.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/sandoz-fesoterodine-fumarate-diester-impurity-out-specification-affected-lots
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by Health Canada, and was posted on the Drug Office website on 17 May 2024.
Ends/Tuesday, Dec 10, 2024
Issued at HKT 15:00
|
| |
|
